Transaction · 0002050167-26-000023

Dandekar Atul

Dandekar Atul, CSBO, reported an open-market or private sale at Maze Therapeutics, Inc. involving 7500.000000 shares for an estimated $206823.75. Reported holdings after the transaction were 26250.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCSBO
MAZEMaze Therapeutics, Inc.
Trade date
Aug 28, 2026
Filing date
Aug 31, 2026
View on SEC Insider profile
Estimated value-$206kShares × reported price
Shares traded7.50k$27.58 per share
Holdings after26.2kDirect
% of reported position traded22.22%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 33,750 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

MAZE price since this filing

Daily closing prices, with the filing date and available return windows
MAZE · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.6%1w ago +10.8%1d ago +7.6%
Returns since7d -1.4%30d +2.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002050167-26-000023
Common Stock
Transaction date
Aug 28, 2026
Filed Aug 31, 2026, 10:32 PM · 3d delay
Shares
7,500 sh
$27.58 per share
Estimated value
-$206k
Computed from shares × price
Holdings after
26,250 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CSBO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.31 to $28.01 per share, inclusive. The reporting person undertake…

  3. F3

    The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Original filing · 0002050167-26-000023
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MAZE